TA Lister

1.3k total citations
32 papers, 1.0k citations indexed

About

TA Lister is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, TA Lister has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 18 papers in Genetics and 7 papers in Oncology. Recurrent topics in TA Lister's work include Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Lung Cancer Treatments and Mutations (5 papers). TA Lister is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Lung Cancer Treatments and Mutations (5 papers). TA Lister collaborates with scholars based in United Kingdom, Australia and Germany. TA Lister's co-authors include Wolfgang Hiddemann, R I Fisher, DL Longo, Bertrand Coiffier, JO Armitage, Fernando Cabanillas, E. H. S. Yau, Derek Davies, Suzanne Jordan and Patrick W. Johnson and has published in prestigious journals such as Blood, British Journal of Cancer and British Journal of Haematology.

In The Last Decade

TA Lister

32 papers receiving 990 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
TA Lister United Kingdom 19 532 405 309 189 175 32 1.0k
Andrew J. Fishleder United States 19 426 0.8× 328 0.8× 315 1.0× 235 1.2× 184 1.1× 50 1.3k
Alex Smith United Kingdom 9 721 1.4× 341 0.8× 581 1.9× 268 1.4× 87 0.5× 16 1.1k
Avrum Z. Bluming United States 19 315 0.6× 452 1.1× 146 0.5× 164 0.9× 98 0.6× 40 1.1k
Deborah Marcellus United States 19 495 0.9× 555 1.4× 240 0.8× 251 1.3× 104 0.6× 30 1.2k
Irène Biasoli Brazil 19 712 1.3× 626 1.5× 171 0.6× 214 1.1× 85 0.5× 44 1.2k
P Colombat France 18 463 0.9× 389 1.0× 275 0.9× 90 0.5× 85 0.5× 48 893
Gregory Reaman United States 12 201 0.4× 227 0.6× 148 0.5× 131 0.7× 288 1.6× 18 921
James W. Lynch United States 16 660 1.2× 458 1.1× 283 0.9× 161 0.9× 44 0.3× 34 1.1k
E. S. Henderson United States 17 193 0.4× 304 0.8× 226 0.7× 176 0.9× 162 0.9× 33 909
Gavin Cull Australia 17 662 1.2× 367 0.9× 601 1.9× 217 1.1× 128 0.7× 67 1.2k

Countries citing papers authored by TA Lister

Since Specialization
Citations

This map shows the geographic impact of TA Lister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by TA Lister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites TA Lister more than expected).

Fields of papers citing papers by TA Lister

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by TA Lister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by TA Lister. The network helps show where TA Lister may publish in the future.

Co-authorship network of co-authors of TA Lister

This figure shows the co-authorship network connecting the top 25 collaborators of TA Lister. A scholar is included among the top collaborators of TA Lister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with TA Lister. TA Lister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cunningham, David, Răzvan Popescu, F. Cavalli, et al.. (1998). Immunotherapy of mantle cell lymphoma (MCL), lymphoplasmacytoid lymphoma (LPC) and Waldenstrom's macroglobulinemia (WM), and small lymphocytic lymphoma (SLL) with rituximab (IDEC-C288): Preliminary results of an ongoing international multicentre trial. British Journal of Haematology. 102. 149–149. 3 indexed citations
2.
Shamash, Jonathan, et al.. (1998). In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma. British Journal of Cancer. 77(10). 1598–1603. 5 indexed citations
3.
4.
Slevin, ML, Patrick B. Wilson, TA Lister, et al.. (1996). Emotional support for cancer patients: what do patients really want?. British Journal of Cancer. 74(8). 1275–1279. 127 indexed citations
5.
Fearnley, Julian, et al.. (1994). Neurological illness following treatment with fludarabine. British Journal of Cancer. 70(5). 966–968. 10 indexed citations
6.
Hickish, Tamas, Pawel J. Serafinowski, David Cunningham, et al.. (1993). 2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies. British Journal of Cancer. 67(1). 139–143. 49 indexed citations
7.
Whelan, Jeremy, Kasia Stepniewska, J. Matthews, et al.. (1993). β-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas. British Journal of Cancer. 67(4). 792–797. 40 indexed citations
8.
Oza, Amit M., TS Ganesan, M. Dorreen, et al.. (1992). Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years. British Journal of Cancer. 65(3). 429–437. 8 indexed citations
9.
Gupta, Ravindra K., et al.. (1992). p53 expression in Reed-Sternberg cells of Hodgkin's disease. British Journal of Cancer. 66(4). 649–652. 28 indexed citations
10.
Gupta, Ravindra K., JS Whelan, TA Lister, BD Young, & J. G. Bodmer. (1992). Direct sequence analysis of the t(14;18) chromosomal translocation in Hodgkin's disease. Blood. 79(8). 2084–2088. 27 indexed citations
11.
12.
Yau, E. H. S., et al.. (1991). Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. British Journal of Cancer. 64(5). 938–942. 59 indexed citations
13.
Rule, Simon, et al.. (1991). Fludarabine phosphate for the treatment of low grade lymphoid malignancy. British Journal of Cancer. 64(1). 120–123. 77 indexed citations
14.
Reznek, Rodney H., et al.. (1991). Computed tomography (CT) and ultrasound (US) guided core biopsy in the management of non-Hodgkin's lymphoma. British Journal of Cancer. 63(3). 460–462. 18 indexed citations
15.
Dorey, E., et al.. (1989). Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL). British Journal of Cancer. 59(5). 772–774. 5 indexed citations
16.
Wagstaff, John, WM Gregory, R. Swindell, D Crowther, & TA Lister. (1988). Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres. British Journal of Cancer. 58(4). 487–492. 49 indexed citations
17.
Webb, J.A.W., et al.. (1988). Low field strength magnetic resonance imaging of the spleen: results from volunteers and patients with lymphoma. British Journal of Cancer. 57(4). 408–411. 6 indexed citations
18.
Webb, J.A.W., et al.. (1988). Low field strength magnetic resonance imaging of bone marrow in patients with malignant lymphoma. British Journal of Cancer. 57(4). 412–415. 30 indexed citations
19.
Ganesan, TS, et al.. (1987). Angio-immunoblastic lymphadenopathy: A clinical, immunological and molecular study. British Journal of Cancer. 55(4). 437–442. 19 indexed citations
20.
Barnett, MJ, et al.. (1987). Chlorambucil and interferon for low grade non-Hodgkin's lymphoma. British Journal of Cancer. 55(2). 225–226. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew J. Fishleder Breakdown of academic impact, for papers by Alex Smith Breakdown of academic impact, for papers by Avrum Z. Bluming Breakdown of academic impact, for papers by Deborah Marcellus Breakdown of academic impact, for papers by Irène Biasoli Breakdown of academic impact, for papers by P Colombat Breakdown of academic impact, for papers by Gregory Reaman Breakdown of academic impact, for papers by James W. Lynch Breakdown of academic impact, for papers by E. S. Henderson Breakdown of academic impact, for papers by Gavin Cull
Rankless by CCL
2026